SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-22-007378
Filing Date
2022-10-31
Accepted
2022-10-31 16:01:49
Documents
2
Period of Report
2022-10-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1705
2 EX 24 POA LYNCH lynchex24.txt EX-24 3538
  Complete submission text file 0001562180-22-007378.txt   6660
Mailing Address 800 HOWARD AVENUE YALE PHYSICIANS BUILDING, 2ND FLOOR NEW HAVEN CT 06519
Business Address
Lynch Thomas J. Jr. (Reporting) CIK: 0001474056 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39634 | Film No.: 221345951

Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Issuer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences